Court prohibited manufacturing and sales of Glivec generics for GIST
The court accepted the Glivec’s use patent of gastrointestinal stromal tumor(GIST), and ordered to prohibit sales and manufacturing of its generics for the indication.
The 12th Civil Department, Seoul Central District Court, ruled the partial winning of the plaintiff at the lawsuit on the merit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
